Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

The Lancet. Oncology·2018
Same author

A tissue-based draft map of the murine MHC class I immunopeptidome.

Scientific data·2018
Same author

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.

Neuro-oncology·2018
Same author

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

Neuro-oncology·2018
Same author

Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

Cancer treatment reviews·2018
Same author

Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.

European journal of cancer (Oxford, England : 1990)·2018

Related Experiment Video

Updated: May 10, 2026

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Primary central nervous system tumors: pathogenesis and therapy

Michael Weller

    Archives of Neurology
    |June 12, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
    10:13

    Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

    Published on: August 12, 2014

    Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
    08:14

    Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

    Published on: September 25, 2012

    Related Experiment Videos

    Last Updated: May 10, 2026

    Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
    05:39

    Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

    Published on: December 27, 2024

    Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
    10:13

    Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

    Published on: August 12, 2014

    Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
    08:14

    Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

    Published on: September 25, 2012